Haichen Pharmaceuticals: Injection of Ceftriaxone Sodium passed the generic drug consistency evaluation.

Haichen Pharmaceuticals announced that it recently received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration, and the injection of Cefmetazole Sodium was approved through generic drug quality and efficacy consistency evaluation. Cefmetazole Sodium for injection is a third-generation cephalosporin antibiotic that works by inhibiting the synthesis of cell walls, effectively killing both gram-negative and gram-positive bacteria. It is a widely used broad-spectrum antibiotic. The approval of the generic drug consistency evaluation for the injection of Cefmetazole Sodium by the company will help enhance the market competitiveness of this drug.